Nursing and Health Professions
Drug Megadose
100%
Metastatic Breast Cancer
100%
Granulocyte Colony Stimulating Factor
100%
Cyclophosphamide
100%
Etoposide
100%
Remission
50%
Platelet Count
50%
Tumor Growth
50%
Liver Vein Obstruction
50%
Neutrophil Count
50%
Event Free Survival
50%
Thiotepa
50%
Engraftment
50%
Gastrointestinal Toxicity
50%
Busulfan
50%
Stem Cell Mobilization
50%
Carboplatin
50%
Diseases
50%
Keyphrases
Cell Transplant
100%
Metastatic Breast Cancer
100%
Initial Treatment
100%
Peripheral Blood Progenitor Cells
100%
Cyclophosphamide
40%
Granulocyte Colony-stimulating Factor (G-CSF)
40%
High-dose Chemotherapy
40%
Complete Response
40%
Etoposide
40%
Second Course
40%
Chemotherapy
20%
Transplantation
20%
Tumor Progression
20%
Adverse Effects
20%
Antitumor
20%
Metastatic Disease
20%
Engraftment
20%
Carboplatin
20%
Complete Remission
20%
Busulfan
20%
Event-free Survival
20%
Thiotepa
20%
Mucocutaneous
20%
Platelet Count
20%
Gastrointestinal Toxicity
20%
Treatment Intensity
20%
Hematologic Recovery
20%
Neutrophil Count
20%
Previously Untreated
20%
Complete Responders
20%
Hepatic Veno-occlusive Disease
20%
Second Transplant
20%
Progenitor Cell Mobilization
20%
Pharmacology, Toxicology and Pharmaceutical Science
Etoposide
100%
High Dose Chemotherapy
100%
Metastatic Breast Cancer
100%
Cyclophosphamide
100%
Granulocyte Colony Stimulating Factor
100%
Chemotherapy
50%
Busulfan
50%
Tumor Growth
50%
Remission
50%
Event Free Survival
50%
Thiotepa
50%
Gastrointestinal Toxicity
50%
Liver Vein Obstruction
50%
Carboplatin
50%
Diseases
50%
Medicine and Dentistry
Metastatic Breast Cancer
100%
Progenitor Cell
100%
Cyclophosphamide
50%
Granulocyte Colony Stimulating Factor
50%
High Dose Chemotherapy
50%
Etoposide
50%
Carboplatin
25%
Thiotepa
25%
Tumor Progression
25%
Metastatic Carcinoma
25%
Platelet
25%
Engraftment
25%
Event Free Survival
25%
Gastrointestinal Toxicity
25%
Neutrophil
25%
Hepatic Veno-Occlusive Disease
25%
Stem Cell Mobilization
25%
Adverse Effect
25%
Busulfan
25%
Diseases
25%
Immunology and Microbiology
Drug Megadose
100%
Granulocyte Colony-Stimulating Factor
100%
Cyclophosphamide
100%
Engraftment
50%
Platelet Count
50%
Event Free Survival
50%
Neutrophil Count
50%